Dina Patel

781 total citations
14 papers, 449 citations indexed

About

Dina Patel is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Dina Patel has authored 14 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Dina Patel's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Dina Patel is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Dina Patel collaborates with scholars based in United States, Brazil and Thailand. Dina Patel's co-authors include Nancy E. Kemeny, Marinela Capanu, Yuman Fong, William R. Jarnagin, Lawrence H. Schwartz, Michael I. D’Angelica, Philip B. Paty, Fidel David Huitzil Melendez, J. Weatherly and Milind Javle and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Annals of Oncology.

In The Last Decade

Dina Patel

12 papers receiving 442 citations

Peers

Countries citing papers authored by Dina Patel

Since Specialization

Citations

This map shows the geographic impact of Dina Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Patel more than expected).

Fields of papers citing papers by Dina Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Patel. The network helps show where Dina Patel may publish in the future.

Co-authorship network of co-authors of Dina Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Patel. A scholar is included among the top collaborators of Dina Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Patel. Dina Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Clients in Uganda accessing preferred differentiated antiretroviral therapy models achieve higher viral suppression and are less likely to miss appointments: a cross‐sectional analysis 2023 ·Journal of the International AIDS Society ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Carolina González, (unknown), (unknown), (unknown), (unknown), Thomas Minior, (unknown), (unknown), (unknown), Dina Patel	5
2	Successful pregnancy following chemotherapy in a survivor of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): A case report and review of literature 2020 ·Gynecologic Oncology Reports ·Natacha Phoolcharoen, Terri L. Woodard, (unknown), Dina Patel, (unknown), (unknown), Mila Pontremoli Salcedo, Michael Frumovitz, David M. Gershenson, Kathleen M. Schmeler	2
3	Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 patients. 2015 ·Journal of Clinical Oncology ·(unknown), Alpa M. Nick, Mark F. Munsell, Pedro T. Ramírez, David M. Gershenson, (unknown), Dina Patel, Patricia J. Eifel, Elizabeth D. Euscher, Kathleen M. Schmeler	0
4	Effectiveness and Toxicity of Vinblastine, Cisplatin, Cyclophosphamide, Bleomycin, Doxorubicin and Etoposide (Vpcbae) in the Management of Patients with Small Cell Carcinoma of the Ovary-Hypercalcemic Type (Sccoht) 2014 ·Annals of Oncology ·(unknown), Pedro T. Ramírez, Alpa M. Nick, J. J. Kavanagh, Elizabeth D. Euscher, (unknown), Dina Patel, Kathleen M. Schmeler	0
5	Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab 2013 ·Annals of Surgical Oncology ·Andrea Cercek, Michael I. D’Angelica, Derek G. Power, Marinela Capanu, Alexandra N. Gewirtz, Dina Patel, Peter J. Allen, Yuman Fong, Ronald P. DeMatteo, William R. Jarnagin, Nancy E. Kemeny	29
6	Hepatic Arterial Infusion and Systemic Chemotherapy for Breast Cancer Liver Metastases 2012 ·The Breast Journal ·(unknown), Komal Jhaveri, Dina Patel, Alexandra N. Gewirtz, Andrew D. Seidman, Nancy E. Kemeny	8
7	Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis. 2011 ·PubMed ·(unknown), Dina Patel, (unknown), (unknown), E. Lin, Harmeet Kaur, Evelyne M. Loyer, J. Weatherly, Milind Javle	51
8	Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: A retrospective analysis. 2011 ·Journal of Clinical Oncology ·J. Weatherly, (unknown), Dina Patel, (unknown), (unknown), Robert A. Wolff, E. Lin, Milind Javle	41
9	Summary of the Causative and Treatment Factors of Diarrhea and the Use of a Diarrhea Assessment and Treatment Tool to Improve Patient Outcomes 2010 ·Gastroenterology Nursing ·Annette Bisanz, Anne M. Tucker, (unknown), Dina Patel, Bianca Calderon, (unknown), (unknown)	5
10	Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion. 2010 ·Journal of Clinical Oncology ·Derek G. Power, Marinela Capanu, Dina Patel, Alexandra N. Gewirtz, William R. Jarnagin, Yuman Fong, Michael I. D’Angelica, Ronald P. DeMatteo, N. E. Kemeny	9
11	A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies 2009 ·Cancer Chemotherapy and Pharmacology ·Archie Tse, Nian Wu, Dina Patel, Dana Haviland, Nancy E. Kemeny	10
12	Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma 2009 ·Journal of Clinical Oncology ·Nancy E. Kemeny, Fidel David Huitzil Melendez, Marinela Capanu, Philip B. Paty, Yuman Fong, Lawrence H. Schwartz, William R. Jarnagin, Dina Patel, Michael I. D’Angelica	221
13	Clinical Use of Anti‐Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer 2008 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Dina Patel	27
14	Responses of Neurologic Complications of AIDS to 3'-Azido-3'-Deoxythymidine and 9-(1,3-Dihydroxy-2-Propoxymethyl) Guanine. I. Clinical Features 1988 ·Clinical Infectious Diseases ·Milan Fiala, Lawrence A. Cone, Nathaniel A. Cohen, Dina Patel, Keith J. Williams, D Casareale, Paul Shapshak, (unknown)	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact